Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain

This study has been completed.

Study NCT00649610 Information provided by Pfizer

First Received: March 28, 2008 Last Updated: April 7, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2003
Estimated Primary Completion Date:	No date given